Ibi, A.; Chang, C.; Kuo, Y.C.; Zhang, Y.; Du, M.; Roh, Y.S.; Gahler, R.; Hardy, M.; Solnier, J.
A 30-Day Randomized Crossover Human Study on the Safety and Tolerability of a New Micellar Berberine Formulation with Improved Bioavailability. Metabolites 2025, 15, 240.
https://doi.org/10.3390/metabo15040240
AMA Style
Ibi A, Chang C, Kuo YC, Zhang Y, Du M, Roh YS, Gahler R, Hardy M, Solnier J.
A 30-Day Randomized Crossover Human Study on the Safety and Tolerability of a New Micellar Berberine Formulation with Improved Bioavailability. Metabolites. 2025; 15(4):240.
https://doi.org/10.3390/metabo15040240
Chicago/Turabian Style
Ibi, Afoke, Chuck Chang, Yun Chai Kuo, Yiming Zhang, Min Du, Yoon Seok Roh, Roland Gahler, Mary Hardy, and Julia Solnier.
2025. "A 30-Day Randomized Crossover Human Study on the Safety and Tolerability of a New Micellar Berberine Formulation with Improved Bioavailability" Metabolites 15, no. 4: 240.
https://doi.org/10.3390/metabo15040240
APA Style
Ibi, A., Chang, C., Kuo, Y. C., Zhang, Y., Du, M., Roh, Y. S., Gahler, R., Hardy, M., & Solnier, J.
(2025). A 30-Day Randomized Crossover Human Study on the Safety and Tolerability of a New Micellar Berberine Formulation with Improved Bioavailability. Metabolites, 15(4), 240.
https://doi.org/10.3390/metabo15040240
